Deerfield Management Company, L.P. (Series C) Roivant Sciences Ltd. Transaction History

Deerfield Management Company, L.P. (Series C)

  • $4.76 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$9.76 - $13.19 $2.44 Million - $3.29 Million
249,513 Added 18.41%
1,604,487 $18.7 Million
Q2 2023

Aug 14, 2023
SELL
$7.09 - $10.08 $2.8 Million - $3.98 Million
-395,026 Reduced 22.57%
1,354,974 $13.7 Million
Q1 2023

May 15, 2023
BUY
$6.92 - $9.98 $12.1 Million - $17.5 Million
1,750,000 New
1,750,000 $12.9 Million

Others Institutions Holding ROIV

# of Institutions
314
Shares Held
495M
Call Options Held
1.29M
Put Options Held
1.15M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.28B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Deerfield Management Company, L.P. (Series C) Portfolio

Follow Deerfield Management Company, L.P. (Series C) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email